Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 815 results for "daiichi sankyo"

Daiichi Sankyo says Ranbaxy founders Malvinder and Shivinder S...

NEW DELHI: Japanese drug maker Daiichi Sankyo has raised a fresh issue in its legal fight against Malvinder and Shivinder Singh, alleging that the former Ranbaxy Laboratories promoters had misled the court by hiding facts about a company they had ... Economic Times, 2 hours ago
No stay on Fortis stake sale plan yet Business Line, 5 days ago

43 images for daiichi sankyo

PharmaVOICE, 2 days ago
VC Circle, 5 days ago
Financial Express, 2 days ago
Pharma Live, 1 week ago
Livemint.com, 2 weeks ago
Money Today, 4 days ago
Pharmaceutical Tech.com, 1 week ago
Financial Express, 4 days ago
PharmaVOICE, 1 month ago
Scrip Intelligence, 1 week ago
PharmaVOICE

Daiichi Sankyo begins phase 1/2 study of U3-1402 in HER3-positive metastatic/unresectable breast cancer patients

Daiichi Sankyo Company Limited has announced the initiation of a three-part open-label phase 1/2 study in Japan with U3-1402, a novel Her3-targeting antibody drug conjugate, in patients with Her3-positive metastatic or unresectable breast cancer who ...
 PharmaBiz2 days ago Daiichi launches Japan-based study of breast cancer candidate U3-1402  Seeking Alpha4 days ago Daiichi Sankyo Release: Company Initiates Phase 1/2 Study Of Novel Antibody Drug Conjugate U3-1402 In Patients With HER3-Positive Metastatic Or Unresectable Breast Cancer  BioSpace4 days ago Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with HER3-Positive Metastatic or Unresectable Breast Cancer  Minyanville4 days ago
[x]  
Money Today

Daiichi-Singh brothers feud: More about arbitration, than about compensation

Delhi High Court is hearing a plea from Japanese drug major Daiichi Sankyo, to prevent the erstwhile promoters of Ranbaxy pharmaceuticals - brothers Malvinder Mohan Singh and Shivinder Mohan Singh - from diluting their stake in Fortis Healthcare. Daiichi's ...
 Money Today4 days ago Delhi High Court agrees to hear Daiichi Sankyo plea on January 23 seeking to block Fortis stake sale  Financial Express5 days ago Delhi High Court accepts Daiichi Sankyo plea to block Fortis stake sale; next hearing on January 23  Financial Express5 days ago Fortis stake sale: Delhi HC to hear Daiichi plea on Jan 23  Money Control5 days ago
[x]  
Financial Express

Daiichi Sankyo-Ranbaxy case: Malvinder Singh, Shivinder Singh assure HC they will not pursue stake sale

A Singapore tribunal had last year ordered the Singh brothers to pay the Japanese drugmaker R2,562-crore damages for concealing information regarding wrongdoing at Ranbaxy while selling it for .6 billion in 2008. Former Ranbaxy promoters Malvinder ...
 Financial Express4 days ago Delhi HC to consider Singh bros-Daiichi case over Ranbaxy on Jan 23  Business Line5 days ago Daiichi moves Delhi HC for restraining dilution of assets by Singh brothers  Livemint.com5 days ago

Deals Buzz: Daiichi Sankyo moves Delhi HC to prevent bid to divest stake in Fortis

In other news, PE firms ChrysCapital, TA Associates eye to invest in Subway franchise platform and Fosun, VC fund Iron Pillar join hands for tech investments in India Mumbai: Mint brings to you your daily dose of top deals reported by newsrooms ...
 Livemint.com5 days ago
Pharmaceutical Tech.com

Daiichi Sankyo Closes Indian Research Division

As you were browsing http://www.pharmexec.com something about your browser made us think you were a bot. There are a few reasons this might happen: You're a power user moving through this website with super-human speed. You've disabled JavaScript ...
 PharmExec.com2 days ago Daiichi Sankyo shuts India R&D division  Pharmaceutical Tech.com1 week ago Daiichi shuts India R&D division  Economic Times1 week ago Abbott to make India hub of global research and development for branded generics  Business Today India2 days ago
FierceBiotech

Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm

E Kumar Sharma New Delhi Last Updated: January 18, 2017 | 16:43 IST On January 10th, in a 100 word press release, Japanese pharma major Daiichi Sankyo announced that the company had decided to "to close its research subsidiary, Daiichi Sankyo India Pharma ...
 Money Today4 days ago DAIICHI SANKYO : Announces Participation in the Global Initiative, Access Accelerated  4 Traders4 days ago Daiichi Sankyo exits vet vaccines  Agra Net1 week ago Daiichi closes India facility in continued R&D overhaul  BioPharma Dive1 week ago
[x]  
Contract Pharma

Kite Pharma, Daiichi Sankyo partner to develop axicabtagene ciloleucel in Japan

Kite Pharma, a clinical-stage biopharmaceutical company, has entered into a strategic partnership with Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) for axicabtagene ciloleucel (approved USAN for KTE-C19) in Japan. Axicabtagene ciloleucel, Kite's lead ...
 PharmaBiz1 week ago Daiichi Sankyo, Kite Pharma in $250M Cancer Pact  Contract Pharma1 week ago Kite Pharma Establishes a Strategic Partnership With Daiichi Sankyo to Develop and Commercialize Axicabtagene Ciloleucel (KTE-C19) in Japan  Nasdaq1 week ago BRIEF-Kite Pharma establishes strategic partnership with Daiichi Sankyo  Reuters UK1 week ago
[x]  

Daiichi Sankyo says Sayonara to India; terminates contract of 170 employees

The company's closure of R&D establishment in Gurgaon marks its exit from Indian market
 Business Standard1 week ago

Kite Pharma joins hands with Daiichi Sankyo for cancer med

Singapore: US based Kite Pharma announced that it has joined hands with Japanese drug giant Daiichi Sankyo to co-develop and commercialize its cancer treatment therapy in Japan. The drug is axicabtagene ciloleucel (approved USAN for KTE-C19) in ...
 Bio Spectrum Asia1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less